Filing Details
- Accession Number:
- 0001447362-21-000150
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-21 16:11:32
- Reporting Period:
- 2021-06-17
- Accepted Time:
- 2021-06-21 16:11:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1447362 | Castle Biosciences Inc | CSTL | Services-Medical Laboratories (8071) | 770701774 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1856542 | W Tobin Juvenal | C/O Castle Biosciences, Inc. 505 S Friendswood Drive, Suite 401 Friendswood TX 77546 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-17 | 5,263 | $2.36 | 8,090 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-06-17 | 4,737 | $2.39 | 12,827 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-17 | 10,000 | $75.40 | 2,827 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Disposition | 2021-06-17 | 5,263 | $0.00 | 5,263 | $2.36 |
| Common Stock | Stock option (right to buy) | Disposition | 2021-06-17 | 4,737 | $0.00 | 4,737 | $2.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 479 | 2027-07-20 | No | 4 | M | Direct | |
| 12,695 | 2028-05-09 | No | 4 | M | Direct |
Footnotes
- These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2021.
- This transaction was executed in multiple trades at prices ranging from $75.00 to $75.90, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- 25% of the 11,484 shares originally subject to the option vested on July 21, 2018, and the remaining shares vest in 36 equal monthly installments thereafter.
- 25% of the 24,610 shares originally subject to the option vested on May 10, 2019, and the remaining shares vest in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
